DUCA, LEONARDO
 Distribuzione geografica
Continente #
NA - Nord America 243
AS - Asia 202
EU - Europa 177
SA - Sud America 23
AF - Africa 1
Totale 646
Nazione #
US - Stati Uniti d'America 241
SG - Singapore 150
IT - Italia 70
HK - Hong Kong 33
RU - Federazione Russa 27
BR - Brasile 21
DE - Germania 21
FI - Finlandia 14
AT - Austria 10
NL - Olanda 8
GB - Regno Unito 7
IE - Irlanda 5
CZ - Repubblica Ceca 4
PK - Pakistan 4
CN - Cina 3
AR - Argentina 2
BE - Belgio 2
CA - Canada 2
ES - Italia 2
IN - India 2
AM - Armenia 1
BD - Bangladesh 1
CH - Svizzera 1
FR - Francia 1
GE - Georgia 1
GR - Grecia 1
ID - Indonesia 1
JO - Giordania 1
KR - Corea 1
LK - Sri Lanka 1
LT - Lituania 1
PH - Filippine 1
PL - Polonia 1
SE - Svezia 1
UA - Ucraina 1
UZ - Uzbekistan 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 646
Città #
Singapore 101
Rome 34
Hong Kong 33
Santa Clara 26
Council Bluffs 20
Engelhard 19
Fairfield 13
Helsinki 12
Ashburn 11
Chandler 10
Nuremberg 10
St. George 9
Wilmington 9
Milan 8
Munich 8
Moscow 6
New York 6
Ann Arbor 4
Brno 4
Seattle 4
Vienna 4
Dublin 3
Lahore 3
Marano di Napoli 3
Amsterdam 2
Ancona 2
Bari 2
Bengaluru 2
Brussels 2
Genzano di Roma 2
Houston 2
Lappeenranta 2
Medford 2
Menlo Park 2
Milazzo 2
Mislata 2
Nepi 2
Newcastle upon Tyne 2
North Shields 2
San Jose 2
São Luís 2
Toronto 2
Villafranca Padovana 2
Xuzhou 2
Amman 1
Athens 1
Barueri 1
Belgrade 1
Belo Horizonte 1
Billings 1
Cabrobó 1
Carangola 1
Carapicuíba 1
Caruaru 1
Catania 1
Caxias do Sul 1
Colombo 1
Conselheiro Lafaiete 1
Coronel Fabriciano 1
Dhaka 1
Durban 1
Frankfurt am Main 1
Gravina di Catania 1
Ho Chi Minh City 1
Islamabad 1
Itaquaquecetuba 1
Jakarta 1
Kilburn 1
Lawrence 1
Los Angeles 1
Miami 1
Naples 1
Palmas 1
Palo Alto 1
Parnaíba 1
Quilmes 1
Rio Grande 1
Saquarema 1
Seoul 1
Shanghai 1
Southwark 1
São Bernardo do Campo 1
São José dos Pinhais 1
São Paulo 1
Tashkent 1
Tbilisi 1
The Dalles 1
Tianguá 1
Vimercate 1
Volta Redonda 1
Yerevan 1
Totale 447
Nome #
Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection 121
Frequency of atypical mutations in the spike glycoprotein in SARS-CoV-2 circulating from July 2020 to July 2022 in central Italy: a refined analysis by Next Generation Sequencing 69
ULTRASENSITIVE HBV-RNA QUANTIFICATION AS A PROMISING BIOMARKER TO OPTIMIZE THE STAGING OF CHRONIC HBV INFECTION AND TO DETECT MINIMAL VIRAL ACTIVITY UNDER PROLONGED VIROLOGICAL SUPPRESSION AND OCCULT HBV INFECTION. 48
null 46
HDV epidemic in Central Italy is stable over the last two decades and is characterized by the circulation of multiple HDV subgenotypes 1 inducing different inflammatory stimuli 42
Ultrasensitive HBV-RNA quantification by droplet digital PCR is a promising biomarker to optimize the staging of chronic HBV infection and to identify minimal viral activity under prolonged virological suppression. 41
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry 40
Long-acting combination of cabotegravir plus rilpivirine: A picture of potential eligible and ineligible HIV-positive individuals from the Italian ARCA cohort 36
Kinetics of HBsAg forms in chronic hepatitis delta patients treated with bulevirtide for 48 weeks: correlation with virological response 36
HDV replicative activity parallels the production of the three HBsAg forms (Large, Middle and Small HBsAg) and its pathogenetic impact is exacerbated by concomitant HBV replication 35
HIV DNA viral reservoirs in blood and gut-associated lymphoid tissues (GALT): Implications of switch from triple antiretroviral therapy (ART) to 2-drug dolutegravir/lamivudine regimens 34
Higher levels of three HBsAg forms (Large, Middle and Small HBsAg) are associated with HDV replication and with the degree of disease and liver damage. 34
KINETICS OF THE THREE HBSAG ISOFORMS ALONG WITH HDV-RNA PREDICT VIROLOGICAL RESPONSE IN CHD PATIENTS TREATED WITH BULEVIRTIDE UP TO 96 WEEKS P 215 30
Stable temporal trend of HDV seroprevalence in central Italy across the last two decades with the circulation of HDV sub-genotypes 1 inducing different inflammatory stimuli 28
Evaluation of HIV-1 DNA levels among adolescents living with perinatally acquired HIV-1 in Yaounde, Cameroon: A contribution to paediatric HIV cure research in Sub-Saharan Africa 25
Kinetics of the Three HBsAg Isoforms along with HDV-RNA Predict Virological Response in CHD Patients Treated with Bulevirtide for 48 Weeks 24
HDV INFECTION IS STABLE IN CENTRAL ITALY ACROSS THE LAST TWO DECADES AND IS CHARACTERIZED BY THE CIRCULATION OF MULTIPLE HDV SUB-GENOTYPES 1 WITH A DIFFERENT PRO-INFLAMMATORY POTENTIAL 24
Prevalence of HDV infection in Central Italy has remained stable across the last two decades with dominance of sub-genotypes 1 and characterized by elevated viral replication 9
Totale 722
Categoria #
all - tutte 4.416
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.416


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202136 0 0 0 0 0 0 27 4 3 0 2 0
2021/202222 1 0 0 3 0 3 4 0 7 1 0 3
2022/202330 2 2 7 1 3 4 2 5 4 0 0 0
2023/2024139 2 0 1 6 4 7 5 1 0 92 5 16
2024/2025495 26 116 81 31 28 67 60 28 46 12 0 0
Totale 722